Studying Genes and Body Chemistry to Understand Metabolic Syndrome and Related Diseases
Looks at biological markers in people with and without metabolic syndrome.
Plain-language title generated from the registry record
Registry title: Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Key facts
- Where
- Taoyuan, TaiwanSee the site
Where in Taiwan
- Chang Gung Memorial Hospitals, LinkouTaoyuan, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chang Gung Memorial Hospital
- Trial code
- NCT07248371
- Record updated
- 25 November 2025
- Original description
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.Read full original descriptionShow less
Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases: A Step Towards Precision Medicine
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
Inclusion: Individuals (male or female) aged 20 years or older; Willing and able to provide written informed consent to participate in the study.
Exclusion: Patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis; Recipients of any organ transplantation; Individuals currently undergoing active cancer treatment; Patients diagnosed with dementia; Pregnant or breastfeeding women.